Skip to content
qps logo

Generic filters
Exact matches only
Search in title
Search in content
Search in excerpt
Contact Us → Apply Now →

  • Home
  • About
    • Staff
    • Safety
    • FAQs
    • Location
    • Blog
  • Studies
    • Available Studies
    • Ongoing Studies
  • Enroll
    • Application
    • Study Process
    • How to Participate
  • Join Our Team
  • Referral Program
  • Contact
qps logo

Generic filters
Exact matches only
Search in title
Search in content
Search in excerpt
Contact Us → Apply Now →

  • Home
  • About
    • Staff
    • Safety
    • FAQs
    • Location
    • Blog
  • Studies
    • Available Studies
    • Ongoing Studies
  • Enroll
    • Application
    • Study Process
    • How to Participate
  • Join Our Team
  • Referral Program
  • Contact

About Clinical Research
Study #40421

This clinical research study will be evaluating the metabolic rate of an investigational drug used together with a marketed HIV medication, and comparing this with a formulation containing both the investigational drug and marketed HIV medication.

Are You a Good Fit?

A man or woman, in overall good health

Between 18 and 55 years of age

Non-smoker/Non-Nicotine for at least 90 day

Body Mass Index (BMI) between 19 and 30 kg/m2

  • Receive up to $4,000 for study-related time and travel for your participation in this study
three young business professionals - full body

What are the Time Requirements?

This study will consist of a four-day in-house stay, return visits and a follow-up phone call. Study dates are as follows:
Group 1
Visit Dates
Stay
Tuesday, October 3, 2023 - Saturday, October 7, 2023
Return
Monday, October 9, 2023 7:00 am
Wednesday, October 11, 2023 7:00 am
Friday, October 13, 2023 7:00 am
Sunday, October 15, 2023 7:00 am
Tuesday, October 17, 2023 7:00 am
Thursday, October 19, 2023 7:00 am
Monday, October 23, 2023 7:00 am
Friday, October 27, 2023 7:00 am
Wednesday, November 1, 2023 7:00 am
Wednesday, November 8, 2023 7:00 am
Wednesday, November 15, 2023 7:00 am
Follow-up Phone Call
Friday, December 1, 2023

How Much: $4,000 (Paid throughout the duration of the study)

Group 2
Visit Dates
Stay
Monday, October 9, 2023 - Friday, October 13, 2023
Return
Sunday, October 15, 2023 9:00 am
Tuesday, October 17, 2023 9:00 am
Thursday, October 19, 2023 9:00 am
Saturday, October 21, 2023 9:00 am
Monday, October 23, 2023 9:00 am
Wednesday, October 25, 2023 9:00 am
Sunday, October 29, 2023 9:00 am
Thursday, November 2, 2023 9:00 am
Tuesday, November 7, 2023 9:00 am
Tuesday, November 14, 2023 9:00 am
Tuesday, November 21, 2023 9:00 am
Follow-up Phone Call
Friday, December 8, 2023

How Much: $4,000 (Paid throughout the duration of the study)

Group 3
Visit Dates
Stay
Tuesday, October 10, 2023 - Saturday, October 14, 2023
Return
Monday, October 16, 2023 8:00 am
Wednesday, October 18, 2023 8:00 am
Friday, October 20, 2023 8:00 am
Sunday, October 22, 2023 8:00 am
Tuesday, October 24, 2023 8:00 am
Thursday, October 26, 2023 8:00 am
Monday, October 30, 2023 8:00 am
Friday, November 3, 2023 8:00 am
Wednesday, November 8, 2023 8:00 am
Wednesday, November 15, 2023 8:00 am
Wednesday, November 22, 2023 8:00 am
Follow-up Phone Call
Friday, December 8, 2023

How Much: $4,000 (Paid throughout the duration of the study)

Group 4
Visit Dates
Stay
Monday, October 16, 2023 - Friday, October 20, 2023
Return
Sunday, October 22, 2023
Tuesday, October 24, 2023
Thursday, October 26, 2023
Saturday, October 28, 2023
Monday, October 30, 2023
Wednesday, November 1, 2023
Sunday, November 5, 2023
Thursday, November 9, 2023
Tuesday, November 14, 2023
Tuesday, November 21, 2023
Tuesday, November 28, 2023
Follow-up Phone Call
Wednesday, December 13, 2023

How Much: $4,000 (Paid throughout the duration of the study)

Group 5
Visit Dates
Stay
Tuesday, October 17, 2023 - Saturday, October 21, 2023
Return
Monday, October 23, 2023
Wednesday, October 25, 2023
Friday, October 27, 2023
Sunday, October 29, 2023
Tuesday, October 31, 2023
Thursday, November 2, 2023
Monday, November 6, 2023
Friday, November 10, 2023
Wednesday, November 15, 2023
Wednesday, November 22, 2023
Wednesday, November 29, 2023
Follow-up Phone Call
Thursday, December 14, 2023

How Much: $4,000 (Paid throughout the duration of the study)

Group 6
Visit Dates
Stay
Thursday, November 2, 2023 - Monday, November 6, 2023
Return
Wednesday, November 8, 2023 8:00 am
Friday, November 10, 2023 8:00 am
Sunday, November 12, 2023 8:00 am
Tuesday, November 14, 2023 8:00 am
Thursday, November 16, 2023 8:00 am
Saturday, November 18, 2023 8:00 am
Wednesday, November 22, 2023 8:00 am
Sunday, November 26, 2023 8:00 am
Friday, December 1, 2023 8:00 am
Friday, December 8, 2023 8:00 am
Friday, December 15, 2023 8:00 am
Follow-up Phone Call
Tuesday, January 2, 2024

How Much: $4,000 (Paid throughout the duration of the study)

BMI Calculator

BMI Calculator Simple

Weight

Unit of measurement*
cm
kg
ft
in
lbs

BMI

Referral Program

Do not forget our REFERRAL PROGRAM. Earn at least $400 paid at dosing. Available to all. for every new participant you refer who completes a study.*

*No referral bonuses are paid out for outpatient vaccine studies.
Handsome man pointing right

All study dates are tentative and subject to change.

We will update the clinical research studies list weekly. Be sure to check with us either by calling or going online. Call (417) 831-2048 or visit 417studies.com for more information. You can also visit the Screening and Recruitment Center located at 2025 W. Sunshine Street, L-109. Office hours are Monday through Friday from 8 a.m. to 5 p.m.

Duration of required contraception for participants assigned female at birth and of childbearing potential enrolled in this clinical study should start from the screening visit until 60 days following administration of study drugs.

Participants assigned female at birth and of childbearing potential must agree to 1 of the following contraceptive methods:

• Complete abstinence from intercourse of reproductive potential. Abstinence is an acceptable method of contraception only when it is in line with the participant’s preferred and usual lifestyle.

Or

Consistent and correct use of 1 of the following methods of birth control listed below:

• Hormonal and nonhormonal intrauterine device
• Bilateral tubal occlusion (upon medical assessment of surgical success)
• Vasectomy in the partner assigned male at birth (upon medical assessment of surgical success)

Or

Participants assigned female at birth and of childbearing potential who initiate use of a hormonal contraceptive > 5 days after onset of menses as their method of birth control should use additional backup contraception (eg, condoms) for 7 days or avoid sexual intercourse for 7 days. Hormonally based contraceptives or barrier methods permitted for use in this protocol are as follows:

• Hormonal methods
 Oral contraceptives (either combined or progesterone only)
 Injectable progesterone
 Subdermal contraceptive implant
 Transdermal contraceptive patch
 Contraceptive vaginal ring
Or

• Barrier methods
 Male condom (with or without spermicide)
 Female condom (with or without spermicide)
 Diaphragm with spermicide
 Cervical cap with spermicide
 Sponge with spermicide

Permanent sterilization includes hysterectomy, bilateral oophorectomy, or bilateral salpingectomy in a participant assigned female at birth of any age.

If you have previously submitted an application, call 417-831-2048 to enroll. Or click on the button below to submit your application now.

Apply Online Now

Signup for our newsletter!

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Important Links

  • Home
  • About
  • Our Studies
  • Ongoing Studies
  • Enroll
  • FAQs
  • Referral Program
  • Join Our Team
  • Blog
  • Contact
  • Privacy Policy

QPS Missouri

QPS Study Campus
1820 W. Mount Vernon Street
Springfield, MO 65802

QPS Screening and Recruitment Center
2025 W. Sunshine Street, L-109
Springfield, MO 65807

Hours of Operation:
Monday – Friday
8 a.m. – 5 p.m.

Call us at 417.831.2048

Employees

  • Employee Portal

qps bird logo outline

Copyright © 2025 QPS Missouri | All Rights Reserved